INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $17,000 | -41.4% | 3,760 | -54.9% | 0.00% | – |
Q4 2018 | $29,000 | -90.5% | 8,330 | -72.5% | 0.00% | – |
Q3 2018 | $306,000 | +39.1% | 30,335 | -0.2% | 0.00% | – |
Q2 2018 | $220,000 | +10.6% | 30,390 | -7.6% | 0.00% | – |
Q1 2018 | $199,000 | -40.6% | 32,874 | -5.6% | 0.00% | – |
Q4 2017 | $335,000 | +29.8% | 34,829 | +19.7% | 0.00% | – |
Q3 2017 | $258,000 | +49.1% | 29,102 | +112.5% | 0.00% | – |
Q2 2017 | $173,000 | +140.3% | 13,695 | +100.9% | 0.00% | – |
Q1 2017 | $72,000 | +213.0% | 6,818 | +178.5% | 0.00% | – |
Q4 2016 | $23,000 | -32.4% | 2,448 | -16.9% | 0.00% | – |
Q3 2016 | $34,000 | +17.2% | 2,945 | +29.0% | 0.00% | – |
Q2 2016 | $29,000 | -23.7% | 2,283 | -4.3% | 0.00% | – |
Q1 2016 | $38,000 | +81.0% | 2,386 | +219.4% | 0.00% | – |
Q4 2015 | $21,000 | -62.5% | 747 | -61.9% | 0.00% | – |
Q3 2015 | $56,000 | -85.5% | 1,960 | -81.8% | 0.00% | – |
Q2 2015 | $387,000 | +6350.0% | 10,788 | +11255.8% | 0.00% | – |
Q1 2015 | $6,000 | -90.0% | 95 | -93.3% | 0.00% | – |
Q4 2014 | $60,000 | -23.1% | 1,425 | -28.8% | 0.00% | – |
Q3 2014 | $78,000 | +56.0% | 2,000 | +25.0% | 0.00% | – |
Q2 2014 | $50,000 | -29.6% | 1,600 | -7.2% | 0.00% | – |
Q1 2014 | $71,000 | +273.7% | 1,725 | +245.0% | 0.00% | – |
Q4 2013 | $19,000 | -94.3% | 500 | -94.7% | 0.00% | – |
Q3 2013 | $332,000 | – | 9,484 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |